Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

170.69
+2.811.67%
Post-market: 170.65-0.0400-0.02%19:30 EDT
Volume:1.92M
Turnover:324.20M
Market Cap:22.91B
PE:-48.72
High:170.85
Open:167.25
Low:165.01
Close:167.88
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.71
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-102.78
PE(LYR):-51.41

Loading ...

FDA Approves New Guardant360 Liquid Cdx, the Largest FDA-Approved Liquid Biopsy Panel With a 100X Expanded Footprint

THOMSON REUTERS
·
May 20

Judge sanctions law firm Quinn Emanuel, citing ethical lapses

Reuters
·
May 20

Guardant Health director Tariq Musa disposes of USD 11,131.36 in shares

Reuters
·
May 20

GH Research Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 19

Guardant Health grants 143,898 RSUs to 267 new employees under inducement plan

Reuters
·
May 19

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

Phase 2b JAMA Data and New Financing Tools Could Be A Game Changer For GH Research (GHRS)

Simply Wall St.
·
May 18

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)

TIPRANKS
·
May 16

These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga Earnings
·
May 15

GH Research price target raised to $35 from $25 at Cantor Fitzgerald

TIPRANKS
·
May 15

GH Research Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
May 15

GH Research Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 15

Canaccord Genuity Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
May 15

GH Research price target lowered to $39 from $42 at Citizens

TIPRANKS
·
May 15

GH Research Launches $200 Million At-the-Market Share Offering With Stifel

TIPRANKS
·
May 15

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings

TIPRANKS
·
May 15

GH Research Reports Widened Net Loss Per Share to $0.31 in Q1 Amid Increased R&D Investment

Deep News
·
May 14

GH Research files $400M mixed securities shelf

TIPRANKS
·
May 14

GH Research reports Q1 EPS (31c), consensus (26c)

TIPRANKS
·
May 14

GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise

TIPRANKS
·
May 14